Biopharma Leaders and Institutional Investors Seeking Effective, Efficient, and Decision-Useful Communications about Long-Term Business Strategy, According to New Report from CECP’s CEO Investor Forum and the Biopharma Sustainability Roundtable. Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained
Read more here